Compile Data Set for Download or QSAR
maximum 50k data
Found 20 of ph data with Target = 'Kallikrein-14'
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113065(US9695194, 2)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113060(US9695194, 1)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataKi:  300nM ΔG°:  -38.7kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113067(US9695194, 3)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113296(US9695194, 13)
Affinity DataKi:  800nM ΔG°:  -36.2kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113068(US9695194, 4)
Affinity DataKi:  1.00E+3nM ΔG°:  -35.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113295(US9695194, 12)
Affinity DataKi:  1.10E+3nM ΔG°:  -35.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113301(US9695194, 17)
Affinity DataKi:  1.10E+3nM ΔG°:  -35.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi:  1.30E+3nM ΔG°:  -34.9kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113119(US9695194, 6)
Affinity DataKi:  1.40E+3nM ΔG°:  -34.8kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113292(US9695194, 9)
Affinity DataKi:  1.50E+3nM ΔG°:  -34.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi:  1.50E+3nM ΔG°:  -34.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50289001(2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazi...)
Affinity DataKi:  2.10E+3nM ΔG°:  -33.7kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113283(US9695194, 8)
Affinity DataKi:  2.30E+3nM ΔG°:  -33.5kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113248(US9695194, 7)
Affinity DataKi:  2.70E+3nM ΔG°:  -33.1kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  5.20E+3nM ΔG°:  -31.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113294(US9695194, 11)
Affinity DataKi: >1.00E+4nM ΔG°: >-29.7kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM33882((5-amino-3-pyridin-3-yl-1,2,4-triazol-1-yl)-(4-chl...)
Affinity DataIC50: >3.00E+4nMpH: 8.0Assay Description:Inhibition of human kallikrein 14 measured after 15 mins at pH 8 by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM33437((5-amino-3-phenyl-1,2,4-triazol-1-yl)-(3,4-dimetho...)
Affinity DataIC50: >3.00E+4nMpH: 8.0Assay Description:Inhibition of human kallikrein 14 measured after 15 mins at pH 8 by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed